Marché des vaccins pour l’aquaculture – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00005403
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[Rapport de recherche] Le marché des vaccins pour l'aquaculture devrait passer de 245,13 millions de dollars américains en 2021 à 569,72 millions de dollars d'ici 2028 ; on estime qu'il croîtra à un TCAC de 12,9 % de 2022 à 2028.



Dans les pratiques aquacoles, il y a toujours un risque d'épidémies pathogènes, ce qui affecte la production de la ferme. Les vaccins aquacoles sont utilisés pour protéger les poissons de tout agent pathogène. La vaccination est une technique simple, fiable et préventive de contrôle des maladies pour l'aquaculture.



Informations sur le marché



La croissance de l'industrie aquacole stimule la croissance du marché



Selon les données dans un rapport intitulé "L'état des pêches et de l'aquaculture dans le monde" publié par l'Organisation des Nations Unies pour l'alimentation et l'agriculture en 2022, la consommation mondiale d'aliments aquatiques, à l'exclusion des algues, a augmenté de plus de cinq fois la quantité consommée il y a près de 60 ans . La consommation mondiale d'aliments aquatiques est passée de 28 tonnes métriques en 1961 à ~158 tonnes métriques en 2019. La consommation a augmenté à un taux annuel moyen de 3,0 % à partir de 1961, contre un taux de croissance démographique de 1,6 %. La consommation par habitant augmente en raison de l'augmentation de l'offre, de l'évolution des préférences des consommateurs et de la croissance des revenus. En 2019, l'Organisation des Nations Unies pour l'alimentation et l'agriculture a estimé la consommation par habitant d'aliments aquatiques pour 227 pays.



Concernant la population, les pays consommant moins que la moyenne mondiale représentaient 54 % de la population mondiale en 2019. La consommation d'aliments aquatiques est la plus élevée en Islande, aux îles Féroé et aux Maldives, qui consomment plus de 80 kg d'aliments aquatiques par habitant et par an. En 2019, la consommation moyenne par habitant dans le monde était de 20,5 kg. Cela variait d'une moyenne de 5,4 kg dans les pays à faible revenu à 26,5 kg dans les pays à revenu élevé. La consommation croissante d'animaux aquatiques accélère la croissance de l'l'industrie aquacole. Les vaccins aquacoles réduisent le risque d'infection et augmentent le rendement des produits. Par conséquent, la croissance de l'industrie de l'aquaculture alimente la croissance du marché des vaccins pour l'aquaculture.



Insights stratégiques < /span>



La prévalence croissante des maladies infectieuses chez les animaux aquatiques offre de nombreuses opportunités pour le marché pendant la période de prévision



Selon l'étude de recherche intitulé "Prevalence of Anisakid Nematodes in Fish in China: A Systematic Review and Meta-Analysis" publié par la National Library of Medicine (NLM) en février 2022, les nématodes Anisakid étaient répandus dans les poissons à travers la Chine avec un taux d'incidence groupé de 45,5%, et le pourcentage d'occurrence pour le poisson frais était le plus élevé (58,1 %). La Chine orientale avait le taux de prévalence le plus élevé de nématodes anisakidés (55,3 %), tandis que la prévalence des nématodes anisakidés (76,8 %) était la plus élevée en mer de Chine orientale. Selon les données publiées dans Aquaculture Research & Journal du développement, environ 219 cas de maladies infectieuses dans le secteur de l'aquaculture fraîche ont été enregistrés de 2014 à 2018. Parmi ceux-ci, 74,88 % étaient parasitaires, 12,80 % étaient bactériennes, 1,83 % étaient virales et 10,50 % étaient des cas mixtes. et les maladies bactériennes. Par conséquent, la forte prévalence des maladies infectieuses devrait stimuler la demande de vaccins, ce qui offrirait des opportunités lucratives pour le marché des vaccins aquacoles dans les années à venir.



Type d'informations basées sur les vaccins



Selon le type de vaccin, le marché des vaccins pour l'aquaculture est segmenté en vaccins vivants, vaccins inactivés, et autres vaccins. Le segment des vaccins inactivés détenait la plus grande part de marché en 2021. Le marché du segment des vaccins vivants devrait croître au rythme le plus élevé au cours de la période de prévision.



Marché des vaccins pour l'aquaculture, par type de vaccin - 2021 et 2028



Marché des vaccins d'aquaculture, par type de vaccin - 2021 et 2028Basé sur les espèces Insights

Le marché des vaccins pour l'aquaculture, basé sur les espèces, est segmenté en tilapia, truite, saumon, crevettes et autres. Le segment du saumon représentait la plus grande part du marché en 2021 et devrait enregistrer le TCAC le plus élevé de 13,4 % au cours de la période de prévision.



Informations basées sur la voie d'administration



En fonction de la voie d'administration, le marché des vaccins pour l'aquaculture est segmenté en injection, immersion et oral. Le segment de l'injection représentait la plus grande part du marché en 2021 et devrait enregistrer le TCAC le plus élevé de 13,1 % au cours de la période de prévision.   



Les entreprises adoptent des stratégies inorganiques et organiques telles que les fusions et acquisitions sur le marché des vaccins pour l'aquaculture. Quelques évolutions récentes du marché sont répertoriées ci-dessous : 



  • En novembre 2022, Indian Immunologicals Ltd (IIL) s'est associé au Central Institute of Fisheries Education (CIFE) pour le développement du premier vaccin pour poisson dans le commerce. Le vaccin sera développé pour la protection des poissons d'eau douce contre les maladies bactériennes courantes.  
  • En août 2021, Elanco Animal Health Incorporated a acquis Bayer Animal Health. La transaction, évaluée à 6,89 milliards de dollars US, a élargi l'échelle et les capacités d'Elanco, positionnant l'entreprise à long terme comme un leader dans l'industrie attrayante et durable de la santé animale. La transaction a ajouté plusieurs marques phares de bétail, étendu la présence aquatique de l'entreprise aux poissons d'eau chaude et amélioré le portefeuille mondial de bioprotection de l'entreprise.
  • En juillet 2020, Zoetis a acquis Fish Vet Group de Benchmark Holdings, PLC , en tant que complément stratégique à son activité Pharmaq, qui développe et commercialise des vaccins pour poissons et offre des services de vaccination et de diagnostic pour l'aquaculture. L'acquisition a amélioré la portée géographique et l'expertise en diagnostic et les services de test, y compris les tests environnementaux, que le laboratoire de référence de Pharmaq, Pharmaq Analytiq, peut offrir aux pisciculteurs sur les principaux marchés de l'aquaculture.     

Profils d'entreprise



  • AquaTactics Fish Health
  • HIPRA SA
  • Merck & Co Inc
  • Microsynbiotix Ltd
  • Indian Immunologicals Ltd
  • Nisseiken Co Ltd
  • Zoetis Inc
  • VETERQUIMICA SA
  • Phibro Animal Health Corp
  • Elanco Animal Health Inc
  • Tecnovax SA
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the aquaculture vaccines market?

The vaccine is used to establish or improve the immunity against a specific disease or group of diseases. In aquaculture practices, there is always a chance of pathogenic outbreaks, which will affect the production of the farm. Aquaculture vaccines are used to protect the fishes from any pathogen. Vaccination is a simple, reliable, and preventative technique of disease for aquaculture.

What are the driving factors for the aquaculture vaccines market across the world?

The factors driving the aquaculture vaccines market growth, includes growing aquaculture industry and the surging demand for aquatic animal-derived food products. However, strict regulatory policies for the approval of vaccines and the high cost of vaccines hinder the aquaculture vaccines market growth.

Who are the major players in the aquaculture vaccines market?

The aquaculture vaccines market majorly consists of the players, such as AquaTactics Fish Health, HIPRA SA, Merck & Co Inc, Microsynbiotix Ltd, Indian Immunologicals Ltd, Nisseiken Co Ltd, Zoetis Inc, VETERQUIMICA SA, Phibro Animal Health Corp, and Elanco Animal Health Inc.

What will be the CAGR of the aquaculture vaccines market during the forecast period?

The market is estimated to grow at a CAGR of 12.9% during the forecast period.

What was the estimated aquaculture vaccines market size in 2021?

The aquaculture vaccines market was valued at US$ 245.13 million in 2021.

What are the growth estimates for the aquaculture vaccines market till 2028?

The aquaculture vaccines market is expected to be valued at US$ 569.72 million in 2028.

Which segment is dominating the aquaculture vaccines market?

The aquaculture vaccines market, by type of vaccine, is segmented into live vaccines, inactivated vaccines, and other vaccines. The inactivated vaccines segment held the largest market share in 2021. However, live vaccines segment is anticipated to register the highest CAGR in the market during the forecast period.

The List of Companies - Aquaculture Vaccines Market

  1. AquaTactics Fish Health
  2. HIPRA SA
  3. Merck & Co Inc.
  4. Microsynbiotix Ltd
  5. Indian Immunologicals Ltd
  6. Nisseiken Co Ltd
  7. Zoetis Inc.
  8. VETERQUIMICA SA
  9. Phibro Animal Health Corp
  10. Elanco Animal Health Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports